| Product |
CAS |
Molecular formula |
More |
| (4Z,7z,10z,13z,16z,19z)-n-(2-hydroxyethyl)-4,7,10,13,16,19-docosahexae |
162758-94-3 |
C24H37NO2 |
More |
| N-palmitoyl-d-sphingomyelin |
6254-89-3 |
C39H79N2O6P |
More |
| Jwh-210 5-hydroxypentyl |
1427521-40-1 |
C26H27NO2 |
More |
| (5Z,8z,10e,14z)-12-hydroxy-5,8,10,14-eicosatetraenoicacid |
71030-37-0 |
C20H32O3 |
More |
| (7E,9e,11e,13e)-5,6,15-trihydroxy-7,9,11,13-icosatetraenoic acid |
171030-11-8 |
C20H32O5 |
More |
| (4Z,7r,8e,10e,12z,14s)-7,14-dihydroxyoctadeca-4,8,10,12-tetraenedioic |
102674-12-4 |
C18H26O6 |
More |
| (5Z,8z,11z,14z)-n-[2-(3,4-dihydroxyphenyl)ethyl]-5,8,11,14-icosatetrae |
199875-69-9 |
C28H41NO3 |
More |
| (5E,8e,12e,14e)-11-hydroxy-5,8,12,14-icosatetraenoic acid |
73804-65-6 |
C20H32O3 |
More |
| N-[(5z,8z,11z,14z)-1-oxo-5,8,11,14-eicosatetraen-1-yl]-l-alanine |
401941-73-9 |
C23H37NO3 |
More |
| (15S,5z,8z,11z,13e)-15-hydroxyeicosatetraenoic acid |
54845-95-3 |
C20H32O3 |
More |
| 5-Benzo[1,3]dioxol-5-yl-n-(2-methylpropyl)penta-2,4-dienamide |
5950-12-9 |
C16H19NO3 |
More |
| 2-[(5Z,8z,11z,14z)-5,8,11,14-icosatetraenoylamino]ethyl dihydrogen pho |
183323-26-4 |
C22H38NO5P |
More |
| N,n,n-trimethyl-2-oxo-2-(phenylamino)-ethanaminium iodide |
22913-17-3 |
C11H17IN2O |
More |
| (3R,6e)-6-(bromomethylene)-3-(1-naphthyl)tetrahydro-2h-pyran-2-one |
478288-90-3 |
C16H13BrO2 |
More |
| (5E)-7-{3-[(1e)-3-hydroxy-1-octen-1-yl]-6,6-dimethylbicyclo[3.1.1]hept |
71111-01-8 |
C24H40O3 |
More |
| Anti-narc-1 |
92693-04-4 |
C20H36O3 |
More |
| (2R)-2,3-bis(octanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate |
19191-91-4 |
C24H48NO8P |
More |
| 1-Benzyl-3-cetyl-2-methylimidazolium iodide |
278603-08-0 |
C27H45IN2 |
More |
| 1Alpha,1beta-dihomo prostaglandin f2alpha |
57944-39-5 |
C22H38O5 |
More |
| 4,5-Dihydro-1-[3-(trifluoromethyl)phenyl]-1h-pyrazol-3-amine |
66000-40-6 |
C10H10F3N3 |
More |
|